ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Industrial biotech firm Verdezyne will receive $48 million from investors led by Malaysian conglomerate Sime Darby Berhad. BP and DSM are also among the investors. Verdezyne engineers yeast to produce biobased chemicals. At a press event in Malaysia, CEO E. William Radany told reporters that the company has chosen Malaysia to build a plant to make the nylon intermediate dodecanedioic acid out of a palm oil by-product. He said the facility will produce 30 million lb per year, about 30% of current world demand.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter